Cargando…
Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
BACKGROUND: Increased reactive oxygen species and estrogen deficiency contribute to the pathophysiology of postmenopausal osteoporosis. Reactive oxygen species contribute to bone degradation and is necessary for RANKL-induced osteoclast differentiation. In postmenopausal bone loss, reactive oxygen s...
Autores principales: | Stubelius, Alexandra, Andersson, Annica, Holmdahl, Rikard, Ohlsson, Claes, Islander, Ulrika, Carlsten, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103594/ https://www.ncbi.nlm.nih.gov/pubmed/27829407 http://dx.doi.org/10.1186/s12891-016-1315-1 |
Ejemplares similares
-
Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis
por: Islander, Ulrika, et al.
Publicado: (2011) -
Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1(*/* )mice with collagen-induced chronic arthritis
por: Jochems, Caroline, et al.
Publicado: (2010) -
Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis
por: Andersson, Annica, et al.
Publicado: (2016) -
Trabecular bone loss in collagen antibody-induced arthritis
por: Grahnemo, Louise, et al.
Publicado: (2015) -
The role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis
por: Engdahl, Cecilia, et al.
Publicado: (2014)